Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study-Reference-Cited by-同舟云学术

Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study

Published:2020-02 Issue: Volume:49 Page:1-7
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Jacquin Jean-Philippe,Uwer Lionel,Savignoni Alexia,Ferrero Jean-Marc,Lortholary Alain,Solub David,Delaporte Flore,Chalabi Nassera,Pibre Sophie,Belkacemi Yazid^ORCID

Funder

ROCHE

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference17 articles.

1. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine;Ross;The Oncologist,2009

2. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Senkus;Ann Oncol,2015

3. Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen;Bittner;Arzneimittelforschung,2012

4. A recombinant human enzyme for enhanced interstitial transport of therapeutics;Bookbinder;J Control Release,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives;Therapies;2021-11

2. Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab;The Breast;2021-06

3. A Comparative Study of the Impact of Coronavirus (COVID -19) on the Therapeutic Practices of Cancer Patients in the Kingdom of Saudi Arabia and Egypt;Journal of Pharmaceutical Research International;2021-03-08

4. Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin®) in Patients With Early HER2-positive Breast Cancer: Real World Data from a German Observational Study - (NIS HerSCin);Anticancer Research;2021-01

5. Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations;Journal of Oncology Pharmacy Practice;2020-06-24